Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Surgical skin antiseptic comparison for prevention of surgical site infection
ACTRN12615000021572Phase 3Completed
- Sponsor
- John Hunter Hospital
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of chlorhexidine, povidone-iodine and ethanol in surgical site infection (SSI) (3 arms), sponsored by John Hunter Hospital. Primary endpoint: Surgical site infection rate. Started Jul 2015; status: completed.
02
Drugs
chlorhexidinepovidone-iodineethanol
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on ACTRN12615000021572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000021572.